THE PITCH: TNeuroPharma received VC funding to commercialize a potential deterrent for Alzheimer's disease
September 21, 2021 at 14:42 PM EDT
The company is commercializing two T-cell products which are meant to work in conjunction, according to Kristina Trujillo, CEO of the startup.
